Koers Mymetics Corporation Other OTC
Aandelen
MYMX
US62856A1025
Biotechnologie & Medisch Onderzoek
Omzet 2021 | 430K 467K | Omzet 2022 | 1,03 mln. 1,12 mln. | Marktkapitalisatie | 8,51 mln. 9,24 mln. |
---|---|---|---|---|---|
Nettowinst (verlies) 2021 | -4 mln. -4,34 mln. | Nettowinst (verlies) 2022 | -4 mln. -4,34 mln. | EV/omzet 2021 | 177 x |
Nettoschuld 2021 | 67,1 mln. 72,81 mln. | Nettoschuld 2022 | 71,68 mln. 77,79 mln. | EV/omzet 2022 | 78 x |
K/w-verhouding 2021 |
-1,86
x | K/w-verhouding 2022 |
-1,77
x | Werknemers | - |
Dividendrendement 2021 * |
-
| Dividendrendement 2022 |
-
| Vrij verhandelbaar | 48,72% |
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Chief Executive Officer | 56 | 01-07-09 | |
Mario Amacker
PRN | Corporate Officer/Principal | - | - |
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Thomas Staehelin
BRD | Director/Board Member | 76 | 02-07-07 |
Ulrich Burkhard
BRD | Director/Board Member | 63 | 23-03-12 |
Marcel B. Rüegg
BRD | Director/Board Member | - | 16-01-23 |
Vaira. 1 jan. | Kapi. | |
---|---|---|
+7,90% | 115 mld. | |
+13,06% | 107 mld. | |
-12,88% | 22,31 mld. | |
-3,99% | 21,6 mld. | |
-6,20% | 18,23 mld. | |
-39,93% | 17,62 mld. | |
+7,08% | 14,26 mld. | |
+32,66% | 12,37 mld. | |
-28,25% | 8,28 mld. |